Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Patient Guide to Clinical TrialsA Phase 1/?1b Study of IAM1363 in HER2 Cancers
Complete Title: A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations
Trial Phase: I
Investigator: Lynn Symonds
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.
Keywords:
- Bladder Cancer; Brain Cancer; Breast Cancer; Central Nervous System (CNS); Gastric Cancer; Solid Tumors; HER2-Positive; Lung Carcinoma, Non-Small-Cell (NSCLC); Colorectal Neoplasms; Gastroesophageal Junction Cancer; HER2
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Request an Appointment